TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ORGO

Organogenesis Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

1.40$ -2.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Organogenesis Holdings Inc (ORGO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 44 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size % Per share
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ORGO
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
– 0.1 – – 6.3 6.6 36 40 51 64 57 65 64 75 62 69 101 107 103 123 114 129 97 121 117 116 108 117 109 100 110 130 115 127 87 101 150 225 37 44 457
0.0 0.2 0.2 0.2 2.9 1.3 1.2 0.9 2.2 18 17 19 19 20 19 20 23 26 25 30 26 33 25 27 26 27 27 26 26 28 29 29 27 31 24 28 36 50 38 24 148
0.0 -0.1 -0.2 -0.2 -2.9 5.3 -1.2 -0.9 -2.2 46 40 46 45 54 43 49 78 81 77 93 88 96 72 95 91 88 81 91 83 72 81 101 88 96 63 73 114 175 -0.9 20 309
– – – – 0.3 0.8 2.8 2.4 2.8 3.1 3.4 3.9 3.9 3.6 5.4 4.7 3.7 6.3 6.2 7.3 9.0 8.3 8.6 10 9.6 11 11 11 10 12 13 16 10 12 11 10 13 10 15 18 57
– – – – 4.3 11 39 38 40 47 49 49 49 52 53 47 51 53 53 62 62 67 64 73 79 63 74 70 64 48 72 77 72 70 73 74 80 100 65 54 299
0.0 0.2 0.2 0.2 2.9 1.3 1.3 61 5.7 51 52 53 53 56 58 51 55 60 64 70 71 76 72 83 89 80 85 81 75 73 85 115 82 85 83 84 93 110 64 71 338
0.0 0.2 -0.2 -0.2 -2.9 -1.3 -1.2 -0.9 -2.2 -4.5 -12 -7.3 -8.3 -1.8 -15 -2.3 23 22 13 24 16 20 -0.1 12 1.8 8.7 -4.0 9.7 8.1 -1.3 -3.9 -14 6.2 10 -20 -11 22 65 -65 -51 -29
– – 0.4 0.6 0.7 0.8 2.4 2.8 2.9 2.7 1.8 2.2 2.4 2.6 2.5 2.9 3.0 2.9 2.5 2.4 1.5 0.9 0.7 0.7 0.6 0.0 0.6 0.6 0.4 0.5 0.5 0.6 0.5 0.1 1.0 0.7 0.4 0.2 – – –
0.0 -0.2 0.1 0.4 -2.1 -0.5 -0.1 0.4 4.9 -9.3 -16 -9.6 -11 -4.4 -16 -5.1 21 19 10 21 13 20 -0.9 11 1.2 8.8 -4.6 9.2 7.6 -1.8 -4.3 -15 5.8 10 -26 -12 21 63 -68 -51 -35
– – – – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.5 0.3 -32 0.0 2.4 1.0 1.3 -1.7 3.9 4.5 -1.2 -2.2 2.5 -6.5 2.6 -6.9 -2.4 -0.4 20 -12 45 52
0.0 -0.2 0.1 0.4 -2.1 -0.5 -0.1 0.4 4.9 -9.3 -16 -9.6 -11 -4.4 -16 -5.2 21 18 9.9 21 13 52 -0.9 8.7 0.2 7.5 -3.0 5.3 3.2 -0.6 -2.1 -17 12 7.7 -19 -9.4 22 44 -56 -99 -90
0.0 -0.2 -0.2 -0.2 -2.9 -0.5 -1.2 -0.9 -2.2 -47 -11 -5.1 -5.9 0.6 -12 -0.5 26 24 16 27 19 25 2.4 15 4.5 13 -0.1 13 14 11 0.1 -9.7 11 15 -20 -5.2 28 70 -56 -47 -4.7

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?